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ABSTRACT 
 
Purpose: To evaluate the immunohistochemical expression of TGFβ1 and E-cadherin 
in OSMF with and without malignant transformation and to determine its usefulness 
to predict malignant transformation. 
 
Material and Methods: A total of 30 OSMF cases were included along with six 
additional archival samples to represent (non-OSMF) for immunohistochemical 
staining. The OSMF cases were categorized into 3-groups on the basis of clinical 
presence or absence of premalignant and malignant features supported by the 
microscopic evidence of normal epithelium as OSMF (Group I), epithelial dysplasia 
as OSMF (Group II) and carcinoma-in-situ and squamous cell carcinoma as OSMF 
(Group III).  
 
Results:  All 30 OSMF and 6 non-OSMF cases exhibited TGFβ1 and E-cadherin 
staining reaction. The TGFβ1 showed moderate to intense nuclear and cytoplasmic 
staining pattern with the latter pattern restricted to OSMF (Group II and III). There 
was positive correlation (Kendall’s tau-b-0.250) between TGFβ1 intensity and 
cytoplasmic E-cadherin staining reaction in the spinous cell layers of OSMF (Group 
II) and III) even in the adjacent normal epithelium. There was a gradual decline of 
membranous E-cadherin staining reaction from OSMF Group II to III with reduction 
of both membranous and cytoplasmic pattern in the invasive front followed gain of 
both patterns in the invasive nests. No statistical significance was observed with any 
histological variables between OSMF Groups except for basement membrane 
thickening in Group I (p=0.027). 
 
Conclusion: The observed cytoplasmic staining pattern with E-cadherin in the 
spinous cell layers close to and away from the focus of epithelial dysplasia, 
carcinoma-in-situ and invasive squamous cell carcinoma may well predict the 
potential for malignant transformation of OSMF in the appropriate clinical context. 
 
Key Words: Immunohistochemistry, TGFβ1, E-cadherin, OSMF, submucous 
fibrosis, epithelial dysplasia, carcinoma, and oral epithelium. 
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INTRODUCTION 
 
Oral submucous fibrosis (OSMF) is a chronic disease of the oral mucosa 
and pharynx characterized by juxta-epithelial inflammation, generalized fibrosis 
of the lamina propria and epithelial atrophy eventually leading to trismus. The 
disease is encountered in most parts of the world, but it has a specific distribution 
and affects predominantly of Asian populations.
1
 Over a decade ago, it was found 
that more than 5 million people are affected in India.
1
 A recent study has 
suggested that patients with OSMF have substantial psychiatric morbidity.
2
 Thus, 
OSMF is regarded as a public health issues in India, and many states have already 
banned the selling of guthka products.
3 
 
Although there is a state wide ban on the sale of certain tobacco products 
since 2001, imposed by the Government of Tamil Nadu, more number of patients 
are diagnosed with OSMF, either with and without progression to squamous cell 
carcinoma, in the author’s hospital setting.  
 
Oral cancer is a significant public health issue, in India, due to low 
treatment outcomes because of delay in diagnosis, as a result of inadequate access 
to health care for rural population or due lack of awareness among low-
socioeconomic group in the urban setting.
4
 According to a recent report, 50% of 
all cancer deaths in India can be attributed to oral and lung cancer in men, with 
40% of all cancers attributable to tobacco use.
5
 Therefore, there is an emergent 
need for early diagnosis of malignant transformation in high-risk individuals 
especially in the context of OSMF. 
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Information obtained from the literature show that acquisition of malignant 
phenotype is not only dependent on alteration in the epithelial cells themselves, 
but is also affected by their interaction with the tumour-associated stroma.
6 
Significantly, the microenvironment of the stroma is emerging as a key mediator 
in the pathogenesis of OSMF and its subsequent malignant transformation.  
 
Available data from the literature implicates TGFβ1 in the pathogenesis of 
OSMF through positive and negative regulations of pro-fibrogenic factors and 
anti-fibrogenic cytokines resulting in disturbing the homeostasis of the 
microenvironment in OSMF.
7
 The implicated substance that induces alteration of 
the microenvironment is the arecoline and arecaidine that are capable of triggering 
normal fibroblasts to become altered fibroblasts responsible for tissue fibrosis in 
OSMF.
7,8,9
 Arecoline is also known to provide cues for inflammation by activating 
and inducing proinflammatory cytokines such as TGFβ1 in epithelial cells.7 The 
essential role of TGFβ1 in oral epithelial tumorigenesis has long been recognized 
either as a suppressor and/or as a promoter during early and later stages of tumour 
evolution.
10
 TGFβ1 inhibits cell proliferation and induces differentiation of 
epithelial cells.
11
 The tumour repressing effects of TGFβ1 is believed to be 
mediated through its receptor TβRII which has been suggested to have tumour 
suppressive function in epithelial tumorigenic process.
6,12
 The tumour promoter 
ability of TGFβ1 is ascribed to its role in mediating the loss of adherens junction 
by down-regulation of E-cadherin leading to reduced cell aggregation and 
enhanced cellular migration,
11,13
 favouring invasiveness and metastasis.
13
 
Therefore, it is likely that TGFβ1 is capable of inducing both fibrosis and 
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malignant transformation in OSMF through the process of epithelial-mesenchymal 
transition by dissociation of E-cadherin adhesion complex.  
 
The E-cadherin is a calcium dependent cell adhesion molecule that forms 
an adherens junction which continuous as a belt around the cell membrane to tie 
epithelial cells to each other and to the extracellular matrix.
14
 Therefore, although 
E-cadherin may regulate diverse processes such as cell division, migration and 
differentiation, the main function of E-cadherin is related to the maintenance of 
cellular integrity of stratified squamous epithelium by aggregation and 
disaggregation.
14
 This is a dynamic event where cells alter their connections with 
one another and with the extracellular matrix by virtue of altered expression of E-
cadherin. However, this is a normally tightly regulated process that facilitates cell 
mobility and turnover.
14
 The loss of cellular cohesion allows cells to disengage 
from their community and is a feature of epithelial dysplasia prior to becoming 
invasive squamous cell carcinoma. 
 
Although a number of sophisticated molecular techniques are available, 
immunohistochemistry is easy to perform and the results can also be reliably 
interpreted in conjunction with H & E sections in an appropriate clinical setting. 
Therefore, the purpose of this study is to explore the usefulness of E-cadherin and 
TGFβ1 immuno-staining to predict malignant transformation of oral epithelium in 
the context of OSMF.  
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AIM AND OBJECTIVES 
AIM 
 To evaluate the expression of E-cadherin and TGFβ1 in oral submucous 
fibrosis (OSMF). 
 
OBJECTIVES 
1. To evaluate the expression pattern of E-cadherin and TGFβ1 in OSMF with 
and without malignant transformation. 
2. To correlate the expression pattern of E-cadherin and TGFβ1 in OSMF with 
and without malignant transformation. 
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REVIEW OF LITERATURE 
 
ORAL SUBMUCOUS FIBROSIS 
 Oral submucous fibrosis (OSMF) is a potentially malignant condition 
frequently associated with the habitual use of areca products characterized by 
progressive submucosal fibrosis of the oral cavity, pharynx and even the upper 
third of the esophagus, subsequently resulting in trismus and dysphagia. The 
prevalence rate in India is about 0.2-0.5% with gender variations.
15
 The age 
ranges between 20 and 40 years.
15
 The higher prevalence in females was related to 
factors like nutritional deficiencies and bias in the sample selection.
16
 Though 
both the genders are at equal risk, the usage of commercially available areca 
products is more among men resulting in male predominance in the recent past 
and about two-thirds of the oral cancer is prevalent in males.
17 
 
 While multiple factors are said to be causing OSMF, epidemiological data 
and intervention studies of the past three decades, point out areca nut as a chief 
etiological agents.
18,19
 The relative risk of developing OSMF increases with the 
duration and frequency of areca chewing.
1
 Areca nut contains alkaloids (arecoline, 
arecaidine, arecolidine, guvacoline, guacine) and flavanoids (tannins and 
catechins).These alkaloids undergo nitrosation and form N-nitrosamines which 
have cytotoxic effect on cells.
1
 The important component arecoline (1, 2, 4, 5-
tetrahydro - 1 – methylpyridine carboxylic acid) has been proved to induce 
collagen synthesis,
1
increased expression of plasminogen activator inhibitor-1
20
, 
cycloxogenase-2
21 
and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1).
22
 
Furthermore, there is evidence to support that areca nut extracts (ANE) decrease 
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collagen phagocytosis by fibroblasts
23
 and increase the collagen stability 
rendering them resistant to collagenase activity.
24
 The catechin and tannins in the 
areca nut stabilize the collagen structure. 
 
 In 1994 Rajendran
25
 et al, had postulated that capsaicin, the active 
ingredient of chillies (Capsicum annum, C. frutescence) can cause 
hypersensitivity and chronic inflammation leading to fibrosis in the oral mucosa. 
Association of iron deficiency anemia and nutritional deficiencies with OSMF 
could be due to the altered inflammatory response in the lamina propria and 
healing, resulting in fibrosis. An autoimmune trigger could also be related with 
OSMF, as the clinical and histological features resemble other collagen-related 
diseases like scleroderma, etc.  
 
 The presence of anti-nuclear antibody (ANA), Smooth muscle antibody 
(SMA) and Gastric-parietal cell antibody (GPCA) in OSMF patients could be 
related to an autoimmune etiology for OSMF.
18 
 
 In 1985 Caniff
26
 et al studied HLA-typing in OSMF patients (n=50) and 
healthy subjects of same ethnic origin and found that there was an increase in the 
frequencies of A10 and DR3 in OSMF patients. The study suggested that OSMF 
being a chronic inflammatory disease was initiated by the areca nut constituents in 
genetically susceptible individuals. 
 
 Genetic susceptibility may be associated with OSMF because raised 
frequencies of HLA-A10, -B7, -A24, DRB1-11, DRB3-0202/3 and -DR3 found in 
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OSMF patients compared to normal subjects.
27
 Moreover, it could be related to 
the distinct geographic and ethnic distribution as well as the development of 
OSMF in patients without the areca chewing habit. 
 
CLINICAL FEATURES  
 In the early stage of the disease, the first symptom is the burning sensation 
while eating hot and spicy food. The mucosa appears erythematous with the 
formation vesicles, mucosal ulcers, petechiea, and the salivation is either 
increased or decreased. These features exacerbate and wane with varying intervals 
of 3 months to 1 year and may present at any stage of the disease. Gustatory 
disturbances and depapillation of tongue pursue with the mucosa becoming pale, 
leathery and hyperpigmented. Fibrous bands become palpable in buccal mucosa, 
faucial pillars and lips imparting marble-like appearance. Bud or hockey-stick 
uvula results with involvement of the soft palate. Mouth opening and tongue 
movements are gradually reduced, causing impairment in food intake and speech. 
Excessive fibrosis of the buccal mucosa produces a sunken-cheek appearance. 
Loss of hearing and nasal voice may occur in extreme cases due to fibrosis of 
auditory tube and nasopharynx respectively.
27 
 
 In 1988 Jain & Suman
28
 et al correlated the severity of the disease and the 
degree of mouth opening. Nevertheless, in Rajendran et al refuted such correlation 
and proved that other factors like site of the involvement, extent of fibrosis, 
involvement of the musculature and the duration of the disease affect the degree 
of mouth opening. Various researchers had proposed different systems for staging 
of OSMF to aid in early diagnosis for a better prognosis.
29,30,31 
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 Recently, More
32
 et al in 2012 proposed a new system of classification 
based on the biological behavior to include the premalignant potential as OSMF is 
often associated with other potentially malignant diseases like leukoplakia. 
 
BIOCHEMICAL FINDINGS 
 Though not specific, significant hematological abnormalities have been 
reported in OSMF, including an increased blood sedimentation rate (ESR), 
anaemia, eosinophila and increased gammaglobulin, decrease in serum iron and an 
increase in total iron binding capacity.
25
 
 
HISTOPATHOLOGY 
 The changes in the epithelium include atrophy to hyperplasia,
 
loss of rete 
pegs,
 
intracellular edema, signet cells, vacuolization of prickle cell layer, 
sawtoothing and liquefaction degeneration of the basal cells, pigment 
incontinence, epithelial keratinization and atypia.
33,34
 Hyperplastic changes 
include hyperkeratosis, acanthosis, parakeratosis, basal cell hyperplasia, 
papillamatosis and pseudoepitheliomatous hyperplasia.
34
 Dysplastic features like 
nulear pleomorphism, prominent nucleoli and mitotic activity have been 
reported.
34 
 
 The lamina propria shows varying degrees of fibrosis and in severe cases, 
hyalinization, atrophic changes in the minor salivary glands and skeletal muscle 
fibres occur. Chronic inflammatory cells like lymphocytes, macrophages, 
eosinophils and mast cells are present, involving the deeper layers. 
Review of Literature 
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 In 1966 Pindborg
35
 et al had described four consecutive stages in 
submucous fibrosis cases based on the presence or absence of edema, nature of the 
collagen bundles, overall fibroblastic response and the state of the blood vessels 
and predominant cell type in the inflammatory exudates. In the very early stage, 
the collagen is fine and fibrillar dispersed with marked edema along with the 
presence of plump, young fibroblasts, dilated and congested blood vessels. The 
inflammation is predominated by polymorphs and occasional eosinophils.  
Juxtaepithelial hyalinization with thick but separate bundles of collagen, moderate 
number of plump fibroblasts, dilated and congested blood vessels characterizes 
the early stages of OSMF. Lymphocytes, eosinophils and occasional plasma cells 
were present. In moderately advanced stages, there is moderate hyalinization with 
spindle shaped adult fibroblasts, mild residual edema, constricted blood vessels 
and inflammatory cells like lymphocytes, plasma cells and occasional eosinophils. 
There is completely hyalinized collagen with no distinct bundles or edema, aged 
fibroblasts, obliterated blood vessels, lymphocytes and plasma cells in the 
advanced stages.
33 
 
 Modifications to Pindborgh's stages were suggested by Utsunomiya and 
Tilakaratne in 2005.
36
 In the early stage, lymphocytes predominate in the 
subepithelial and edematous connective tissue zones. As the disease progresses, 
there is reduction of inflammation, granular changes in the muscle layer and 
compression of blood vessels by the fibrous bundles. The advanced stage is 
characterized by marked fibrosis, reduction in the number of blood vessels, 
hyaline changes extending to the muscle layers showing degenerative changes.
33 
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PATHOGENESIS 
 OSMF is a collagen metabolic disorder caused by alterations in the process 
of extra cellular matrix remodeling leading to progressive fibrosis. The chemical 
and mechanical irritation caused by the areca components induces juxtaepithelial 
inflammation. Pre-existing iron and vitamin B12 deficiencies make the oral 
mucosa susceptible to trauma and increased absorption of areca substances.
1
 
Chronic exposure to betal quid results in the persistence of the inflammation and 
prostaglandin production.
21
 Inflammation is predominated by T cells and 
macrophages which secrete various cytokines and growth factors like TNF α, IL-6 
and TGFβ1. 
 
TGF-BETA AND COLLAGEN PRODUCTION PATHWAY 
 TGFβ is the key regulator in extra cellular matrix remodeling and has been 
implicated in wound healing, fibrotic disorders and OSMF. Both collagen 
production and degradation pathways are regulated by TGFβ. The procollagen 
genes namely COL1A2, COL3A1, COL6A1, COL6A3 and COL7A1 have been 
identified as targets of TGFβ and hence result in increased production in OSMF. 
The procollagen proteinases (PNP, PCP) cleave the procollagen precursors into 
collagen fibrils and their levels increase as result of TGFβ stimulation. The cross-
linking of the collagen fibers takes place by the action of lysyl oxidase (LOX) 
enzyme, making it resistant to proteolysis. Conversion of the inactive precursor 
pro-lysyl oxidase into its active form is mediated by BMP1, which in turn 
enhanced by TGFβ. The active form of LOX contains copper and lysine 
tyrosylquinone (LTQ) as cofactors which are essential for cross-linking of 
collagen fibers. The oxidated flavanoids form quinones which might resemble 
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LTQ and enhance LOX activity. Furthermore, increased levels of copper in 
OSMF enhance LOX activity thereby tilting the balance towards a fibrotic 
condition.
1 
 
TGF-BETA AND COLLAGEN DEGRADATION PATHWAY 
 Matrix metalloproteinases (MMPs) are endopeptidases playing an essential 
role in extra cellular matrix remodeling by degradation. MMP1, MMP8 and 
MMP13 are collagenases, the activation of which occurs after endoproteolytic 
cleavage. MMPs are regulated at the level of transcription, zymogen activation 
and by endogenous inhibitors. In addition, the flavanoids have an inhibitory effect 
on collagenase action. Tissue level activities of MMPs are inhibited by TIMPs 
(TIMP1, 2, 3, 4) and play a crucial role in ECM remodeling during development, 
wound healing, inflammatory disorders, tumor invasion and metastasis. TGFβ 
modulate the degradation pathway by activation of tissue inhibitor of matrix 
metalloproteinase gene (TIMP) and plasminogen activator inhibitor gene (PAI). 
One of the earlier targets of TGFβ is TIMP1 gene in fibroblasts, which after 
induction inhibit collagenase resulting in reduced collagen degradation. The 
plasminogen activation system is an extracellular matrix remodeling system in 
which, the inactive plasminogen is cleaved by tissue plasminogen activator (tPA) 
bound to fibrin and urokinase plasminogen activator (uPA) bound to a specific 
cell receptor to form active plasmin. Plasmin contributes to activation of pro-
MMPs, thereby facilitating collagen degradation. These plasminogen activators in 
turn are regulated by plasminogen activator inhibitor (PAI1, PAI1& PA2). The 
stimulation of PAI by TGFβ causes reduction in collagen degradation. TGFβ 
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mediated stimulation causes decreased production of active collagenase and 
inhibition of existing collagenase ultimately resulting in fibrosis.
1 
 
MALIGNANT TRANSFORMATION OF OSMF 
 In 1984 Pindborg
37
 et al did a prospectively analysis to evaluate the 
malignant potential of OSMF in the Indian population. Among the 66 patients, 3 
of them developed carcinoma (4.5%) period of 4 to 15 years. During this period, 
13% developed carcinoma, leukoplakia (26%), epithelial dysplasia (26%) and 
atrophic epithelium (76%) clearly indicating the precancerous nature of OSMF. 
 
 In 1985 Murti
38
 et al did a prospective study to evaluate the rate of 
malignant transformation in 66 oral submucous fibrosis patients during a 17 year 
period. Five of them developed oral squamous cell carcinoma (7.6%). The 
malignant transformation rate was 4.5% over a 15-year observation period. The 
study results conveyed the malignant potential of OSMF. 
 
 In 2007 Hsue
39
 et al did a follow-up study to estimate the rate and the time 
to transformation in a group of patients from southern Taiwan with potentially 
malignant oral epithelial lesions. Among the 1458 subjects with oral potentially 
malignant disorders, the malignant transformation rates of oral submucous fibrosis 
with and without dysplasia were 5.4% and 1.09% respectively.  
 
 In 2008 Thilakaratne
40
 et al analyzed the role of hypoxia in malignant 
transformation of OSMF by the expression of hypoxia-inducible factor-1α (HIF-
1α) in OSMF epithelium. The early epithelial changes in the basal cell layer such 
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as basal cell hyperplasia were considered as mild dysplasia. The expression of 
HIF-1α in the epithelium and the presence of dysplasia correlated significantly 
and the over expression of HIF-1α in OSMF may indicate the role of hypoxia in 
malignant transformation of OSMF. 
 
 In 2009 Ho
41
 et al did a retrospective cohort study to estimate the 
malignant transformation rate of oral potentially malignant disorders (OPMDs)  
namely epithelial hyperplasia, dysplasia, verrucous hyperplasia and oral 
submucous fibrosis in Taiwanese population during a period of 37.8 months. The 
malignant transformation rate for epithelial dysplasias was 8-24%. None of the 
OSMF cases showed malignant transformation during the follow-up period and 
was due to the small sample size (n=4). 
 
 In 2011 Hashmi
42
 et al prospectively analyzed the clinical behavior of oral 
cancer in patients with and without submucous fibrosis (Group B and A 
respectively). Among the 288 study subjects, the incidence of submucous fibrosis 
was 9%. Oral cancers with concurrent OSMF were well to moderately 
differentiated types with reduced tumor thickness and metastasis (N1) when 
compared with oral cancers without OSMF (moderate to poorly differentiated 
forms with N2 metastasis) and the differences were statistically significant. The 
study results suggested that the oral cancers with submucous fibrosis had better 
prognosis than those not associated with OSMF. 
 
 In 2014 Wang
43
 et al did a follow-up study to estimate the malignant 
transformation rate of various potentially malignant disorders in Taiwanese 
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population. Among the 5071 subjects with oral potentially malignant disorders, 
4.84% of oral submucous fibrosis patients with dysplasia and 3.72% of oral 
submucous fibrosis patients without dysplasia showed malignant transformation 
during the follow-up period of 42.47 and 37.42 months respectively. The study 
also revealed that the risk of malignant transformation was 1.89 times higher for 
patients with dysplastic changes of precancerous lesions than for those without 
dysplastic change. 
 
EPITHELIAL-MESENCHYMAL TRANSITION IN OSMF 
 Malignant transformation is associated with the change in the phenotype of 
the epithelial cells. They lose their epithelial characteristics and transform into a 
mesenchymal phenotype known as epithelial mesenchymal transition (EMT). 
EMT is a complex process involving multiple signaling pathways, leading to the 
spectrum of changes in the epithelial cells including loss of cell adhesion, polarity 
and acquisition of cell motility. Basically, EMT plays a vital role during 
embryogenesis (type I), tissue repair, regeneration and organ fibrosis (type II) and 
malignancies (type III).
44
 EMT regulators are aberantly expressed in cancers and 
are less coordinated than developmental EMT. Various EMT inducers include 
Transforming Growth Factor-β (TGFβ), Wnt, Snail/Slug, Twist and Six1 
signaling pathways and in breast cancer, TGFβ involvement in EMT has been 
proven. E-cadherin, an adherens junction protein is essential for epithelial cell 
integrity which is affected or lost during EMT and as a result, the cell acquires a 
migratory phenotype. EMT enables the cancer cells to invade and metastasize, 
hence associated with poor prognosis.
45
 EMT changes are evident in both 
precancerous and cancerous lesions. 
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 In 2013 Das
46
 et al analyzed the role of EMT in OSMF and its malignant 
transformation using immunohistochemistry, real time-PCR and microarray 
techniques. Expressions of E-cadherin and few other EMT biomarkers were 
assessed by IHC and PCR analysis in normal (n=16) and OSMF (without 
dysplasia, n=25; with dysplasia, n=30) tissues. In normal mucosa and OSMF 
without dysplasia (OSMFWT), E-cadherin expression was membranous, with 
reduced intensity in the basal layers of OSMF tissues. There was a reduction in 
the membranous expression, but the cytoplasmic expression in the basal and 
suprabasal cells increased in OSMF grades in comparison to normal mucosa.  
Downregulation of E-cadherin in dysplasias suggested the possibility of EMT in 
the pathogenesis of malignant transformation.  
 
ROLE OF TGFβ 1 IN EMT AND CARCINOGENESIS 
 In 1993 Glick
47
 et al did experimental study in mice to understand the role 
played by TGFβ1 in carcinogenesis. Low and high risk papillomas were generated 
in mice skin and analyzed for TGFβ1 & 2 expression using 
immunohistochemistry, in situ hybridization and PCR techniques. The basal 
layers of the normal epidermis and the low-risk papillomas expressed TGFβ1. The 
expression was lost in high-risk papillomas, squamous cell carcinomas and 
correlated with basal cell hyperproliferation. In tumors, loss of TGFβ1 was 
associated with the expression of keratin13, a marker for malignant 
transformation, and hence it could be a risk factor in malignant progression.  
 
 In 1994 Zhang
48
 et al carried out an in-vitro analysis by continuously 
exposing the normal rat liver epithelial cells with TGFβ1, which resulted in the 
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generation of TGFβ1 resistant strains. In addition, there was increase in the 
anchorage-independent growth capacity, tumorigenecity and multidrug resistance 
in the TGFβ1 exposed epithelial cells, implicating that TGFβ1 had promoted 
spontaneous neoplastic transformation. 
 
 In 1997 Gao
49
 et al conducted a study to investigate the significance of 
TGFβ1in OSMF pathogenesis by employing in situ hybridization technique. 
Paraffin embedded tissue blocks of OSMF, lichen planus and normal mucosal 
tissues were used to determine the TGFβ1 mRNA in the keratinocytes. The 
keratinocytes in the early and middle stage OSMF samples (60%) expressed 
TGFβ1 mRNA, whereas there was no expression in the keratinocytes of lichen 
planus and normal mucosal tissues, suggesting that TGFβ1 may be synthesized 
from the keratinocytes of OSMF tissue and act as a mediator in the OSMF 
pathogenesis. 
 
 In 1998 Haque
50
 et al studied the expression of various inflammatory 
mediators including TGFβ in the frozen sections of OSMF and normal buccal 
mucosa. The intensity and distribution of TGFβ in OSMF was upregulated with 
strong expression in both the epithelium and the connective tissue. 
 
 In 2000 Ebert
51
 et al retrospectively assessed the expression of TGFβ1 in 
gastric cancers (n=19), tumor-free gastric mucosa of gastric cancer patients, 
gastric mucosa of first-degree relatives of gastric cancer patients (n=18) and 
healthy volunteers (n=19), using RT-PCR and IHC in German population. There 
was an increased frequency of TGFβ1 expression of in the gastric cancer tissues 
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and in the gastric mucosa of first-degree relatives differing significantly from the 
normal control tissues (p<0.0001). Gastric mucosa in the tumor-free areas of 
gastric cancer patients also expressed TGFβ1 The study has demonstrated the 
increased possibility of developing gastric cancer in the first-degree relatives 
relating to TGFβ1 mediated malignant transformation. 
 
 In 2002 Xiong
52
 et al conducted a retrospective study to analyze the 
relationship of TGFβ1 and angiogenesis in colorectal cancers. The study samples 
were surgically resected colorectal adenocarcinomas (n=98) in which the TGFβ1, 
VEGF expressions and microvascular density (MVD) were analyzed 
immunohistochemically and graded (+ve if more than 10% stained tumor cells). 
TGFβ1 expression was significantly high in stages III-IV, T3-T4 with metastatic 
lymph nodes. TGFβ1 positivity correlated significantly with increased expression 
of VEGF. The study had demonstrated the angiogenic potential of TGFβ which 
occurred through the up-regulation of VEGF. 
 
 In 2004 Lu
53
 et al compared the expression of TGFβ1 in head and neck 
squamous cell carcinomas and the adjacent normal tissues. Over-expression of 
TGFβ1 was noted in the SCCs. In transgenic mice, TGFβ1 induced severe 
inflammation, angiogenesis and epithelial hyperproliferation. The study suggested 
that tumorigenic role of TGFβ1 in SCC of head and neck could be an early event 
in carcinogenesis. 
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 In 2008 Magdalena
54
 et al did an immunohistochemical analysis to study 
the expression of markers related to proliferation, apoptosis,  hormone receptors 
and downstream elements of TGFβ signaling pathway in benign prostrate 
hyperplasia tissue specimens (n=16). There was an upregulation of downstream 
mediators (such as pSmad 3, Snail, and Slug) of TGFβ signaling pathway in areas 
showing EMT changes as evidenced by the loss of E-cadherin and increased 
vimentin expression. The study suggested that TGFβ mediated EMT of the 
epithelial and the endothelial cells might be the cause for the accumulation of 
mesenchyme-like cells in the stroma resulting in benign prostrate hyperplasia 
rather than mere stromal proliferation. 
 
 In 2009 Li
55
 et al did a retrospective study in the Chinese population to 
analyze the expression of CD34, α-SMA and TGFβ1 in intraepithelial neoplasias 
and squamous cell carcinomas of cervix  thereby elucidating their diagnostic 
importance and the mechanism of myofibroblast formation. The study samples 
were obtained from cervical biopsy and hysterectomy specimens and were 
grouped into invasive squamous cell carcinoma, low and high grade intraepithelial 
neoplasia and normal cervical tissues. After immunohistochemical analysis, scores 
of 0 (negative), 1(10-50%-focal positive) and 2 (>50%-strong positive) were 
given for cytoplasmic expression of TGFβ1. In normal cervical mucosa the basal 
and supra basal cells along with the stromal cells (inflammatory cells and 
endothelial cells) TGFβ1 expression was noted in the cytoplasm. With increase in 
the severity of neoplasia, the TGFβ1 expression showed statistically significant 
increase in the tumor cells and the stromal cells between invasive SCC, 
intraepithelial neoplasias (p=0.035-high grade; p=0.009-low grade) and normal 
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cervical tissues (p=0.000). The α-SMA showed  significantly increased expression 
in high grade and scc groups. The study results suggested that increased TGFβ1 
expression by the tumour cells could have mediated the myofibroblasts 
transformation resulting in more invasive forms. 
 
 In 2010 Illeperuma
56
 et al retrospectively analyzed the relationship 
between the expression of profibrogenic and antifibrogenic cytokines and fibrosis 
and their role in malignant transformation of oral submucous fibrosis. The study 
groups were OSMF without dysplasia (n=23), OSMF with dysplasia (n=19) and 
normal controls (n=8). The expression of TGFβ1, TIMP1 and MMP1 were semi-
quantitatively analyzed immunohistochemically. There was an increased 
expression of TGFβ in OSMF which may be a contributing factor for fibrosis. 
There was no correlation between deregulated collagen remodeling and epithelial 
dysplasia. 
 
 In 2010 Bellone
57
 et al demonstrated the association between endoglein, 
TGFβ1 and TGFβR II expression and angiogenesis during neoplastic 
transformation of colon mucosa by immunohistochemistry and PCR techniques. 
Study samples were biopsied tissues (adenomas, n=32) and resected 
adenocarcinomas (n=57). In most severe dysplastic adenomas, TGFβ1 was 
significantly upregulated and its expression was inversely related to disease-free 
survival. 
 
 In 2010 Logullo
58
 et al retrospectively analyzed the expression of various 
EMT markers including TGFβ1, E-cadherin etc, in breast ductal carcinomas to 
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demonstrate their correlation with disease progression and overall survival. The 
study samples were obtained from invasive ductal carcinoma cases (n=55) and 
ductal carcinoma in situ (DCIS) cases (n=95, 50 contained invasive component). 
Immunohistochemical analysis of TGFβ1, E-cadherin, β-catenin, Snail and c-Met 
was carried out. Scoring was given based on the percentage of the positively 
stained cells (≤10% - negative; 10-25% -positive +; 25-50% - ++ and ≥50% - 
+++). 78.2% of the invasive cases showed cytoplasmic staining of tumor cells and 
the increase in the expression from DCIS to invasive forms was statistically 
significant (p=0.001). Tumors in advanced stages and lymph node metastasis had 
significant TGFβ1 expression (p=0.018 and 0.012 respectively). TGFβ1 
expression showed no significant difference between DCIS cases with and without 
invasive components. Membranous expression of E-cadherin was noted in 74.5% 
cases and it was completely lost in 5 cases. The difference in E-cadherin 
expression between the DCIS and the invasive cases was not significant. 
Significant positive association (p=0.001) was observed between TGFβ1 and E-
cadherin in DCIS cases. No correlation was found between the EMT markers and 
patient survival.  
 
 In 2011 Khan
59
 et al did a gene expression profiling in OSMF and normal 
tissues by employing microarray analysis. Upregulation of TGFβ1 was 
demonstrated and it was proved by the strong immunoreactivity of SMAD in 
OSMF cases. When the keratinocytes and the oral fibroblasts were treated with 
TGFβ, there was an upregulation of CTGF and few other genes that were 
previously identified to be upregulated in microarray analysis. All these studies 
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implicate that TGFβ pathway is activated in OSMF to cause fibrosis as well as 
malignant transformation.  
 
 In 2011 Meng
6
 et al studied expression of TβRs in the premalignant 
lesions and carcinoma-associated fibroblasts. TβRII- and III levels are reduced in 
the oral epithelium and stroma  (carcinoma-associated fibroblasts). 
 
 In 2013 Ma
60
 et al, conducted retrospective study in gastric precancer and 
cancer cases (n=93) to analyze the role of TGFβ1 and -β2 in carcinogenesis. The 
study groups comprised resected primary gastric cancer specimens (n=30), 
neoplastic and cancerous biopsy specimens (n=43) and normal gastric mucosal 
samples free from neoplasia or inflammation (n=20). These groups were 
categorized after histopathological examination as normal, low/high grade 
intraepithelial neoplasias and early/advanced gastric cancer cases. The samples 
were analyzed for TGFβ1 and TGFβ2 expression using immunohistochemistry 
and qRT-PCR. Positive intracellular staining of TGFβ1was noted in 5% or more 
dysplastic/malignant cells and smooth muscle actin expressing fibroblasts. The 
percentage of expression increased with the lesion progression from normal to 
cancer (20% - normal controls, 52.3% - precancer, 59.1% -early gastric cancer, 
66.7% - advanced gastric cancer), which was statistically significant (P=0.002). 
There was no correlation between TGFβ1 expression and lymph node 
involvement. TGFβ1 mRNA levels are higher in tumor areas and advanced gastric 
cancer cases. Serum levels of TGFβ1 and -β2 were significantly higher in both 
early and advanced cancer cases. Study results suggest TGFβ1 increased during 
neoplastic transformation. 
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 In 2013 Xu
61
 et al did a cross-sectional study in Chinese population to 
examine the role of TGFβ1 and hepatocyte growth factor in esophageal 
carcinogenesis and angiogenesis. The study groups were normal controls (n=20), 
subjects with esophageal intraepithelial neoplasia (low grade, n=26; high grade, 
n=44), CIS (n=23) and SCC (n=23). The specimens were subjected to 
immunohistochemical analysis of TGFβ1, HGF, α-SMA and CD34 proteins. 
Scoring was given based on the percentage of positive staining (cytoplasmic) cells 
(0, 1, 2, 3 for <10%, 10-25%, 26-50% and >51% respectively) for TGFβ1.  The 
proliferative cells in the basal zone, tumour and the dysplastic cells, stromal 
fibroblasts and the inflammatory cells in the tumour fronts expressed TGFβ1. 
There was a significant increase in the expression of TGFβ1with increasing grades 
of dysplasia. Correlation between TGFβ1 and α-SMA was significant, indicating 
TGFβ1 induced α-SMA expression by the atypical (AF) and the cancer-associated 
fibroblasts (CAF). Mean vascular diameter (MVD) was high in TGFβ1 positive 
groups which indicate the angiogenic potential of TGFβ1. The TGFβ1 secreted by 
the AFs and CAFs contribute to the malignant transformation of esophageal 
precancerous lesions through angiogenesis. 
 
 In 2013 Kim
62
 et al retrospectively studied the differential expression of 
TGFβ1and E-cadherin in Mongolian population affected by lung 
adenocarcinomas. Based on the invasive component, the study samples (n=65) 
from the resected lung adenocarcinoma specimens were grouped and 
immunohistochemically analyzed for TGFβ1and E-cadherin expression. 
Membranous positivity of E-cadherin (>90%) and cytoplasmic staining of TGFβ1 
(>10%) were considered positive. The invasive foci showed an increased 
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expression of TGFβ1 (p=0.001) and the noninvasive areas expressed E-cadherin 
more (p=0.009). Correlation between them was significant in the noninvasive 
components. The results demonstrated the increase in TGFβ1expression was prior 
to the destruction by invasive tumor cells and loss of E-cadherin expression, 
suggesting that TGFβ1over-expression was an initial event in invasive process. 
  
 In 2013 Imai
63
 et al did a retrospective analysis to demonstrate the role of 
TGFβ1 in promoting microinvasion of small lung adenocarcinomas. Among the 
study samples obtained from surgically resected non-small cell lung carcinoma 
cases (n=453), adenocarcinoma in situ (AIS, n=22) and minimally invasive 
adenocarcinoma (MIA, n=23) subtypes were immunohistochemically evaluated 
for TGFβ1expression and scored using the Allred 8-unit system. 65.2% of MIA 
cases expressed TGFβ1. It was significantly higher (p<0.05) when compared to 
the AIS group where only 27.3% cases were TGFβ1positive. The MIA group had 
a significantly higher (P=0.0017) median Allred score for TGFβ1expression than 
the AIS group. The study results suggested that there is a possible relation 
between increased TGFβ1expression and microinvasion in small lung 
adenocarcinomas. 
 
 In 2013 Tirino
64
 et al investigated the role of TGFβ1 in EMT of cancer 
stem cells (CSCs) of A549 cell fraction.  The TGFβ1 treated cells lost their 
epithelial morphology, assumed fibroblast-like shape with downreglation of E-
cadherin and an upregulation of vimentin. The migratory potential and motility of 
the cells in the CD133
+
 sublines increased. The study suggested that TGFβ1 
probably have influenced EMT changes in the cell lines. 
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 In 2013 Kale
65
 et al studied the role of TGFβ1 in lipodystrophy in OSMF. 
The study samples were early (n=24) and advanced cases (n=60) of OSMF. The 
TGFβ1 expression in the epithelium was present in the basal layer (55%), 
superficial layer (32%) or both (13%). The intensity of TGFβ1 staining in the 
epithelium and the stroma was assessed as negative (no staining); + mild (positive 
staining for less than one-third of tissue section); ++ moderate (positive staining 
area ranged from one-third to two-third of tissue section) and +++ intense 
(positive staining for more than two-third of tissue section). In the stroma, the 
fibroblasts, inflammatory cells and the endothelial cells showed positivity. There 
was no statisticl difference between in relation to TGFβ1 expression in early and 
advanced cases or its expression in the basal layer, superficial layer and the 
stromal cells. There was no statistical significant difference in relation to TGFβ 
expression in early and advanced OSMF or in its expression in superficial and 
basal layer of epithelium, stromal cells and also in deeper stroma.  The study 
results have suggested that increased expression of TGFβ1 in the early stages 
might have affected lipogenesis eventually causing lipodystrophy in OSMF.  
 
 In 2014 Kamath
66
 et al did a quantitative immunohistochemical analysis of 
TGFβ1expression in different histological grades of OSMF. The study samples of 
OSMF (n=58), normal mucosa (n=10) and scar tissue (n=5) were analyzed for 
immunohistochemical expression of TGFβ1. The grade I OSMF cases had 
maximum epithelial expression which gradually reduced to that of normal 
epithelium in grade III OSMF.  The spinous cell layer of all tissues showed 
intense staining, with highest percentage in grade II OSMF cases. Blood vessels, 
muscles and submucosal fibers showed positivity. In grade III OSMF cases, the 
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skeletal muscle expression was high. There was an increase in the proportion of 
TGFβ1expression in the submucosa with increasing grades OSMF and the grade 
III cases had the highest proportion. The study suggested the possible role of 
TGFβ1in the fibrosis of OSMF.  
 
 In 2014 Salvadori
67
 et al retrospectively analyzed the expression of Ki-67, 
TGFβ1and elastin in actinic cheilitis (AC) and lower lip squamous cell carcinoma 
(LLSCC). Ki-67 and TGFβ1 levels were inversely correlated in both the cases 
when compared to the normal labial epithelium. 
 
EMT AND E-CADHERIN 
 In 1998 William
68
 et al evaluated the expression of cadherins and catenins 
in the dysplastic epithelium of carcinomas and normal mucosa to appreciate their 
role in oral carcinogenesis. The study samples namely the normal mucosa (n=8), 
dysplastic mucosa (n=12) and carcinomas (n=12) were analyzed for the 
expression of E-, P-cadherins and catenins (α, β, γ). The membranous expression 
of E-cadherin was scored based on the intensity of staining (0=absent; mild=+; 
moderate=++; strong=+++) and the cytoplasmic staining was recorded as either 
present or absent. In mild to moderate dysplasias the membranous expression of 
E-cadherin was similar to the normal epithelium. With the increase in the severity 
of the dysplasia, the membranous expression was reduced and the cytoplasmic 
staining increased in CIS. The well/moderately differentiated carcinomas and the 
central area of tumor islands expressed moderate membranous staining and it was 
lost in the periphery of the tumor islands and deep invasive margins. The 
cytoplasmic staining was present in all carcinomas. The reduction in the 
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expression of E-cadherin  in the areas of dysplasias and carcinomas suggest that it 
could be a late event associated with tumor invasion. 
 
 In 1993 Oka
69
 et al did a cross-sectional study to evaluate the relationship 
between E cadherin expression, invasiveness and metastasis of breast carcinomas. 
Surgically resected breast cancer specimens (n=120) and metastatic lymph nodes 
(n=19) were semi quantitatively evaluated for E cadherin and EGFR expression. 
The tumors were graded as uniformly E-cad positive (>90% expression), 
hetreogenous E-cadherin positive (10-90% expression) and uniformly negative 
(<10% expression). The expression of E-cadherin was considered to be preserved 
(Pr type) in E-cadherin positive tumors and reduced (Rd type) in tumors with 
absent/heterogenous expression. Non-invasive and papillary carcinomas showed 
preserved type E-cadherin expression; whereas reduced type expression was noted 
in invasive and poorly differentiated forms. Strong relationship between E-
cadherin expression and growth pattern was proved. Cells with impaired E-
cadherin expression tend to grow infiltratively, but, E-cadherin positive cells 
showed an expansile growth pattern. E-cadherin expression was similar to the 
primary tumor in most of the metastatic lymph nodes. 
 
 In 1993 Doki
70
 et al did an in vitro analysis of E-cadherin expression and 
its significance in invasion and metastasis in cell clones from human esophageal 
cancer using flow cytometry, immunofluorescent cytochemistry, cell aggregation 
and cell dissociation assay techniques. The cell clones with E-cadherin positivity 
had higher adhesive capacity than the E-cadherin negative cells and formed 
cobble-stone colonies. In an organotypic raft culture, these cell clones formed a 
Review of Literature 
 
27 
complete stratified squamous epithelium. On treatment with monoclonal 
antibodies for E-cadherin the mutual adhesive capacity was reduced and showed 
invasion. This study could explain that when there is loss or dysfunction of E-
cadherin, the intercellular adhesion is reduced and the cells attained the invasive 
behavior. 
 
 In 1993 Downer
71
 et al studied the expression of E-cadherin in normal, 
hyperplastic and malignant oral epithelium. The normal and hyperlastic 
epithelium showed strong pericellular staining in the basal, suprabasal and prickle 
cells layers not involving the keratinized superficial layers. On the other hand in 
SCCs, the heterogenous staining pattern with areas of loss or fragmentation of 
staining was present. The study suggested that the loss of E-cadherin might be 
important in the invasive process. 
 
 In 1998 Nawrocki
72
 et al did in vitro analysis of cytoplasmic redistribution 
of E-cadherin –catenin complex and its association with downregulation of 
tyrosine phosphorylation of E-cadherin in bronchopulmonary carcinomas. The 
cytoplasmic redistribution of E-cadherin was observed in restricted invasive nests 
and never in in-situ lesions. The authors’ suggest that such redistribution could 
result in invasive phenotype. 
 
 In 2002 Bankfalvi
73
 studied the alterations of the cell-adhesion molecules 
during oral carcinogenesis and tumour progression. The basal layers of the normal 
epithelium expressed E-cadherin in the basal cells, whereas in carcinomas, there 
was loss of E-cadherin in the invasive tumor front, metastatic as well as recurrent 
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lesions. The findings indicate that there is some perturbed expression of adhesion 
molecules during the stepwise course of oral carcinogenesis and tumour 
progression. 
 
 In 2004 Shih
74
 et al studied the expression and correlation of E-cadherin 
and β-catenin in the normal endometrium and endometrial carcinomas. There was 
a reduction of E-cadherin and cytoplasmic β-catenin expression as well as an 
increase in the nuclear staining reaction of the latter in endometrial carcinomas 
when compared to the proliferating normal glandular cells. 
 
 In 2004 Gasparoni
75
 et al did an in vitro analysis to compare the 
expression of differentiation markers such as structural proteins, adhesion 
molecules (E-cadherin, integrin), plasma membrane lipid composition and 
intercellular junctions between the normal and squamous cell carcinoma cell lines 
using immunohistochemistry, Western blot analysis, lipid analysis and electron 
microscopy. In normal epithelium E-cadherin staining was located at the 
plasmamembrane extending from the basal to the upper layers. In squamous cell 
carcinoma cell lines, the intensity was reduced with weak membranous staining as 
well as some cytoplasmic staining. The study results suggested that the expression 
of E-cadherin and other differentiation markers vary with the degree of 
differentiation; hence the expression was reduced in the less differentiating 
squamous cell carcinomas. 
 
 In 2005 Vogelmann
11
 et al did an in vitro analysis to study the effect of 
TGF β1 on cell-cell adhesion and cell migration in pancreatic carcinoma cells. 
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The study demonstrated the reduction of E-cadherin-catenin complexes after 
treatment with TGF β1 and was mediated by PI3-kinase and PTEN.  
 
 In 2008 Mandal
76
 et al studied the expression pattern of E cadherin, 
vimentin and p-src proteins in HNSCC cell lines and primary SCC tissue 
specimens by using Western blot analysis, IHC and functional techniques. In 
normal mucosa, well-differentiated and moderately-differentiated squamous cell 
carcinomas and broad invasive fronts E-cadherin expression was membranous, 
whereas, in poorly differentiated forms, both membranous and cytoplasmic 
expression was observed. In sarcomatoid squamous phenotypes and finger-
like/individual tumor cell invasive fronts, the expression was either weak or lost. 
Vimentin was detected in the tumor cells. The results revealed the inverse 
correlation between p-Src and E-cadherin expression, thus substantiating the 
association of these proteins and EMT in HNSCC. 
 
 In 2010 Das
77
 et al studied the expression of p63, E-cadherin and CD105 
to evaluate of the malignant potential of OSMF. The membranous staining 
reaction to E-cadherin showed a reduction in the basal layers of OSMF with and 
without dysplasia, with the maximum loss in the latter.  There was significant 
variation (p<0.0001) in E-cadherin intensity within and between the tissues 
(normal and diseased). 
 
 In 2011 Yogesh
78
 et al retrospectively analyzed the expression of E-
cadherin and Cathepsin-D to find their correlation with the dysplastic changes in 
the premalignant lesions. The study groups, namely the premalignant lesions 
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(n=22), oral squamous cell carcinomas (n=8) and normal mucosa (n=10) were 
subjected to immunohistochemical analysis for the expression of E-cadherin and 
Cathepsin-D. In normal mucosa, the basal, suprabasal and the prickle cell layers 
showed membranous E-cadherin expression and is absent in the superficial layers. 
In the dysplastic epithelium the loss of E-cadherin expression had a perfect 
correlation (Goodman-Kruskal gamma correlation) with increased nuclear 
cytoplasmic ratio, increased mitotic figures, very large correlation with 
pleomorphism and moderate correlation with basilar hyperplasia, loss of cohesion, 
loss of polarity and prominent nucleoli. The drop-shaped rete peg areas had small 
correlation with E-cadherin expression. In squamous cell carcinomas, E-cadherin 
expression was heterogenous and reduced. Staining was either lost or patchy in 
small tumor islands and the individual tumor cells.  
 
 In 2012 Hashimoto
79
 et al conducted a retrospective study to analyze the 
role of cadherin switch in oral carcinogenesis. The study samples were 
incisional/excisional biopsies of oral carcinoma cases (n=63) and normal oral 
epithelium. Immunohistochemical analysis of E-cadherin and N-cadherin was 
done. The membrane- and cytoplasm-positive cells were separately calculated. 
There was a significant difference in the membranous expression of E-cadherin 
between different grades of tumor differentiation and invasiveness. The well-
differentiated and low invasive forms express more when compared to the least 
differentiated and most invasive forms. The expression was more at the centre of 
the tumor mass than at the periphery or the invasive front. 
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 In 2012 Grigoras
80
 et al did a retrospective analysis of E-cadherin 
expression in non-small cell lung carcinomas and their association with clinical 
parameters employing immunohistochemistry. The study samples (n=47) were 
surgically resected pulmonary carcinoma specimens. E-cadherin expression was 
scored based on the percentage of the membranous positive cells (<5%-negative, 
5-50%-weak positive and >50%-strong positive). The patterns of expression were 
linear (continuous and uniform membranous staining), patchy (discontinuous 
membranous staining) and diffuse (membranous and cytoplasmic staining). The 
relationship between E-cadherin expression and different grades of carcinoma was 
insignificant. There was a significant correlation between reduced E-cadherin 
expression and lymph node metastasis. 
 
 In 2012 Chaw
81
 et al did an immunohistochemical evaluation to predict 
role of EMT biomarkers (E-cadherin, β-catenin, APC and Vimentin) in the 
malignant transformation of oral mucosa. The study groups comprising normal 
mucosa (n=18), dysplasia of varying grades (mild, n=27; moderate/severe, n=8; 
OSCC, n=47) were analyzed immunohistochemically and immunoreactivity 
scores were computed. The expression of E-cadherin decreased with increasing 
grades of dysplasia but the difference was not statistically significant. In the 
organotypic human oral mucosa equivalent (HOME) culture model, E-cadherin 
expression was present in the epithelial layers but was absent in the individual 
invasive cells. The study concluded that oral carcinogenesis could be related to the 
alteration in the molecules such as E-cadherin which affect the Wnt signaling 
pathway, thereby inducing EMT. 
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 In 2013 Gonzalez – Moles82 et al reviewed the usefulness of various 
cancer stem cell markers in oral cancer. The under expression of E-cadherin in the 
premalignant fields associated with the risk of multiple tumor development had 
been observed. Due to the lack of specificity, the role of E-cadherin as a cancer 
stem cell marker in oral cancer is not clear. 
 
 In 2013 Tavares
83
 et al investigated the expression of E-cadherin and β-
catenin in normal epithelium, dysplasias, carcinoma in situ, and primary oral 
squamous cell carcinomas (OSCC). Membranous staining reaction of E-cadherin 
in the normal and dysplastic epithelium showed a reduction in CIS and SCC. 
There was an increase in cytoplasmic staining reaction in the SCCs. There was a 
loss or reduction of membranous immunostaining and a gain of cytoplasmic 
staining of cadherin-catenin complex occur as the lesion progresses from 
dysplasia to oral squamous cell carcinomas. 
 
 In 2013 Rosado
84
 et al evaluated the expression and localization of E-
cadherin and β-catenin complex in SCCs. The membranous staining intensity to 
E-cadherin ranged from weak (16%), moderate (30%) and high (28%). In 
addition, cytoplasmic staining reaction was noted in a single case. 
 
 In 2014 Zhai
85
 et al retrospectively evaluated the expression of E-cadherin 
and apoptotic related proteins (DRP-1, ezrin) in esophageal squamous cell 
carcinoma (ESCC) using ISH and IHC techniques. The study samples were 
surgically resected ESCC specimens (n=76) from patients without the history of 
prior chemotherapy or radiotherapy and associated paracancerous normal 
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epithelium (n=76). The membranous staining of E cadherin and cytoplasmic 
staining of DRP-1 and ezrin were considered positive. Absent/cytoplasmic 
expressions of E cadherin were considered negative. The basal and the spinous 
cell layers of cancerous and paracancerous epithelium express E cadherin in their 
membranes. The difference in E cadherin expression with varying grades of 
carcinoma was significant and the expression was high in well-differentiated 
forms (P=0.006). There was a significant association between the lymph node 
metastasis and E cadherin expression (P=0.006). The expression is reduced in 
metastatic cases. There was no significant association with the age, gender, tumor 
size and invasiveness. 
 
 In 2014 Auerkeri
86
 et al conducted a retrospective analysis in Indonesian 
population to evaluate the expression of E-cadherin and cyclin-dependent kinase 
inhibitor in head and neck squamous cell carcinomas. The study samples were 
obtained from primary squamous cell carcinoma tumors (n=45) and metastatic 
tumors (n=12). Malignancy scores (MS) were calculated from histological 
sections. The immunoreactivity score for E-cadherin was calculated using the 
staining intensity scores and percentage of positive cells. Statistically significant 
correlation was not observed between reduced E-cadherin or p27
kip1 
expression 
and the severity of malignancy.  
 
 In 2014 Pectasides
87
 et al did a retrospective study in the Greek population 
to quantitatively analyze the role of proteins associated with EMT (EGFR, β-
catenin, E-cadherin) in the prognosis of HNSCC. The study samples were primary 
HNSCC cases (n=67 after exclusion) and normal mucosa (n=10). Tissue 
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microarray sections were subjected to fluorescent immunohistochemical analysis 
to detect the expression of E-cadherin EGFR and β-catenin. Automated image 
acquisition and analysis (AQUA) was executed and AQUA scores were 
computed. There were significant correlations between increased expression of E-
cadherin, superior progression-free survival (p=0.04) and overall survival 
(p=0.05). 
 
 In 2014 Mohtasham
88
 et al did a retrospective analysis of E cadherin and 
matrix metalloproteinase-9 expression in the histologically negative surgical 
margins of OSCC specimens in Iranian population. The study groups were OSCC 
samples (n=58) categorized into grades I, II and III and their tumor-free margins. 
E cadherin and MMP-9 expressions were analyzed immunohistochemically. 
Reactive Scores were computated. The cell membrane positivity was considered 
as preserved reactivity and the cell membrane with nuclear positivity as altered 
reactivity. Intensity E cadherin expression was significantly higher in early stage 
tumors (preserved and altered reactivity) than the late stage tumors (altered 
reactivity) and their respective surgical margins.  
 
 In 2014 Chan
89
 et al did a cross-sectional study to analyze the prognostic 
potential of E-cadherin and Galectin-9 expression in oral squamous cell 
carcinomas. The study samples included OSCC cases with and without lymph 
node metastasis (n=13 & n=19 respectively), reactive mucosal lesions (n=6) and 
normal buccal mucosa (n=5). Immunohistochemical analysis was done and 
histochemical scores were calculated for E cadherin and Galectin-9. The basal and 
parabasal layers and the central part of the tumor islands showed strong 
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membranous positivity for E cadherin with the intensity reducing gradually 
towards the surface. Reduced E cadherin expression was noted in OSCC and in 
the invasive tumor front. The study concluded that there was no significant 
correlation in E cadherin expression and lymph node metastasis. 
 
 In 2014 Anura
90
 et al did a retrospective study to determine the malignant 
potentiality and progression of OSMF in different stages by assessing the intensity 
and spatial expression of epithelial marker E-cadherin and neo-angiogenic 
molecules (VEGF & CD105) at the proliferative and differentiative zones of the 
epithelium. 63 buccal mucosal biopsy specimens were categorized as normal 
mucosa (n=10), OSMF without dysplasia (n=18), OSMF with different grades of 
dysplasia (n=40). The cytoplasmic and membranous expressions of E cadherin 
were scored separately based on the intensity of staining. VEGF expression in the 
cytoplasm and ECM was scored. Microvessels expressing CD105 within 100µm 
range below the basement membrane were counted. In normal epithelium, the 
proliferative zone expressed predominant cytoplasmic E cadherin and the 
membranous form was expressed in the differentiative zone. In an OSMF 
epithelium, E-cadherin expression was reduced significantly in the proliferative 
layer and the differentiative layers with the later showing increased cytoplasmic 
expression. The loss of membranous expression was significant between OSMF 
groups with moderate and severe dysplasia. The cytoplasmic expression was 
significantly high in severely dysplastic OSMF but the membranous expression 
was reduced.  
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 In 2014 Hanemann
91
 et al retrospectively analyzed the prognostic role of 
cadherin-catenin complex in basaloid squamous cell carcinomas. The study 
samples namely basaloid squamous cell carcinomas (n=17) and squamous cell 
carcinomas (well/moderately differentiated, n=28; poorly differentiated, n=26) 
with comparable tumor site and clinical stage were immunohistochemically 
analysed for E-cadherin and β-catenin expression. After summation of the scores 
based on the proportion of positive tumor cells (0,1,2 for ≤10%, 11-50% and 
>50% respectively), intensity (0,1,2 for absent, weak and strong immunostaining 
respectively) and cellular localization (0,1,2 for absent, cytoplasmic/nuclear and 
membranous immunostaining respectively), the samples with scores 0-4 were 
classified as absent/weak immunostaining group and those with scores 5-6 were 
placed under strong immunostaining group. Strong membranous expression of E-
cadherin was observed in 40% of W/MDSCCs, whereas PDSCCs (19%) and 
BSCCs (12%) expressed strong cytoplasmic expression. There was statistically 
significant difference in E-cadherin expression between the two groups (p=0.019). 
There was no significant correlation between the expression of E-cadherin and β-
catenin and lymph node micrometastasis, overall and disease-free survival rates 
among the study groups. 
 
 In 2014 Yun
92
 et al retrospectively analyzed the association of EMT with 
the prognosis of colorectal cancer. The study samples of colorectal carcinomas 
(stage III, n=409) were examined immunohistochemically for the expression of E-
cadherin, vimentin and α-smooth muscle actin. The well/moderately differentiated 
forms expressed E-cadherin and the reduced E-cadherin expression was one of the 
indicators of poor prognosis in terms of disease-free survival (p=0.016). 
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MATERIALS & METHODS 
 
This study was undertaken in the Department of Oral and Maxillofacial 
Pathology, Tamil Nadu Government Dental College and Hospital, Chennai, India. 
This is the only Government Institution under the Ministry of Health and Family 
Welfare in the state of Tamil Nadu. The average out-patient who attends this 
institution is around 800 per day, with annual statistics of 359, 471 patients for the 
year 2014. The clinical records and preserved archival tissue samples are available 
from 1970 and clinical photographs are available from 2008. Therefore, the 
present study was undertaken utilizing the available clinical information for 
OSMF patients. The cases were selected only when basic clinical information 
including habits, clinical staging and photographs are available. As diagnosis of 
OSMF is generally made on clinical grounds, for the purpose of including normal 
OSMF in this study, ethical permission and clearance was obtained for taking 
biopsy. The representative clinical photographs of the OSMF Groups are shown in 
Figure-1.  
 
A total of 30 OSMF cases were included. In addition,   six archival 
samples to represent (non-OSMF) cases were also included. The OSMF cases 
were categorized into 3-groups. OSMF (Group I) comprised of patients without 
any clinical indicators of premalignant and/or malignant features. OSMF (Group 
II and III) consists of patients with clinical indicators of premalignant and/or 
malignant features. However, OSMF Group II consists of cases with microscopic 
evidence of epithelial dysplasia (mild or moderate), whereas Group III comprises 
of cases with microscopic evidence of carcinoma-in-situ and invasive squamous 
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cell carcinoma. Serial tissue sections of 4-µm thickness for routine haematoxylin 
and eosin stain and for immunohistochemistry were made from formalin-fixed, 
paraffin embedded tissue blocks and verified histologically for the presence of 
normal OSMF and OSMF with epithelial dysplasia (moderate to 
severe/carcinoma-in-situ) or invasive squamous cell carcinoma. All the three 
OSMF Groups formed the study groups. Of the total 30 OSMF cases, 6 were 
included in OSMF (Group I), 14 in (Group II) and 10 in (Group III). In the 6 
(non-OSMF) cases (reactive fibrous lesion/fibroma and mucocele), the 
epithelium with areas of atrophy and hyperplasia were specifically examined.  
 
All OSMF Groups were evaluated histologically for the presence of type 
and nature of epithelium, epithelial dysplasia, and invasive squamous squamous 
cell carcinoma, hyaline material within the epithelium, thickening of the basement 
membrane, subepithelial inflammation, vascularity and fibrosis.  
 
Immunohistochemistry to analyse intensity and pattern of staining reaction 
was performed for all cases using antibody to E-cadherin and TGFβ1 as according 
to the manufacturers protocol and briefly described below. The tissue sections 
from the formalin-fixed, paraffin embedded placental tissue were used as a 
positive control for TGFβ1and the normal epithelium for E-cadherin  
immunostaining. The same tissue without the primary antibody is considered as 
negative control. 
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IMMUNHISTOCHEMISTRY 
ARMAMENTARIUM  
The armamentarium used in this study is listed in the Box-1 
Box-1 
1. Leica Microtome (LEICA RM 2245) 
2. Autoclave  
3. Hot air oven  
4. Slide warmer  
5. Couplin jars  
6. Measuring jar  
7. Weighing machine  
8. APES coated slides  
9. Slide carrier  
10. Leica Microtome (LEICA RM 2245) 
11. Autoclave  
12. Hot air oven  
13. Slide warmer  
14. Couplin jars  
15. Measuring jar  
16. Weighing machine  
17. APES coated slides  
18. Slide carrier  
19. Micro-pipettes  
20. Toothed forceps  
21. Electronic timer  
22. Beakers  
23. Rectangular steel tray with glass rods  
24. Cover-slips  
25. Research microscope (OLYMPUS BX43)  
 
REAGENTS 
1. Concentrated HCl 
2. Tris – EDTA buffer 
3. Tris – Buffer saline 
4. Deionised distilled water 
5. Absolute alchol 
6. Xylene 
Materials and Methods 
 
40 
BUFFERS 
TRIS-EDTA antigen retrieval buffer (TRIS-EDTA) 
 For one liter of solution, 6.05 g of TRIS and 0.75 g of EDTA were dissolved 
in distilled water and the pH was adjusted to 9. 
 
TRIS-BUFFERED SALINE (TBS) 
For one liter of solution, 0.604 g of TRIS and 8 g of sodium chloride were 
dissolved in distilled water and the pH was adjusted to 7.4 using 0.1N Hcl. 
 
ANTIBODIES (Figure-2) 
1. Primary antibody TGF beta-1(V) (1:100 dilution, Rabbit polyclonal 
antibody, sc-146) was purchased from Santa Cruz Biotechnology, Inc.  
2. Primary antibody E-cadherin (1:100 dilution, Rabbit polyclonal antibody, 
Clone-EP 6, CAT# PRO 39) was purchased from PathnSitu 
Biotechnologies, Livermore CA, USA. 
3. Secondary antibody - PolyExcel HRP/DAB detection system was 
purchased from PathnSitu Biotechnologies, Livermore, CA, USA. 
 
PROCEDURE 
Four-µm tissue sections were cut and transferred into APES coated slides. 
The sections were then incubated at 60-70 C for 1 hour. Deparaffinization was 
carried out by treating with 2 changes of xylene, 5 minutes each. The sections 
were treated with descending grades of alcohol (Absolute alcohol- two changes, 
90% and 70% alcohol- 5 minutes each) and rehydrated with distilled water (two 
changes, 2 minutes each). The slides were then transferred to tris - EDTA buffer 
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(pH - 9) in a pressure cooker for antigen retrieval for 15 minutes. The slides were 
dipped in distilled water for 5 minutes each. Washing was carried out using Tris-
buffered saline (TBS, pH-7.4) for 2 minutes. Endogenous peroxidase was blocked 
by adding H2O2 on the sections for 5 minutes and twice washed in the wash buffer 
for 2 minutes each. 
 
The primary antibodies (TGFβ1, E-cadherin) were added to the sections 
and incubated for 30 minutes in a moist chamber. The primary antibodies were 
washed using the wash buffer 2 times for 2 minutes each. Polyexcel Target binder 
reagent was added.  After 15 minutes, the sections were washed in two changes of 
buffer for 2 minutes each. 
 
After the above steps, the polyexcel horseradish peroxidase was added to 
the sections which was then incubated for 15minutes and subsequently washed 
with buffer for two changes for 2 minutes. Following this procedure, 3,3'-
diaminobenzidine tetrahydrochloride (DAB) chromogen (1ml DAB Buffer +1 
drop DAB Chromogen) was added to the sections and kept for 2 - 5minutes and 
then washed in distilled water. The counterstaining was done with hematoxylin for 
30 seconds and washed with water. Throughout the procedure appropriate care 
was taken not to dry the sections. The slides were then transferred to 70% alcohol 
followed by 100% alcohol and finally with one change of xylene. The tissue 
sections were mounted with DPX and then observed under the microscope. 
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EVALUATION OF EXPRESSION PATTERN OF E-CADHERIN AND 
TGF β1 STAINED SECTIONS 
The E-cadherin immuno-stained sections were evaluated as follows: 
1) Positive reaction – the visualization of a brown colored immuno-stained 
product in the target areas is considered as positive expression. The 
localization is based on membranous, cytoplasmic and nuclear or perinuclear 
patterns and the location of the immunostained cells is based on as to whether 
they are in the basal, suprabasal and spinous cell layers as shown in the  
Table-1. 
 
2) Intensity of the staining reaction – The staining is interpreted as mild, 
moderate and intense and scored as shown in Table-1. The Kappa analysis 
was done to compare the interobserver variability with regard to intensity of 
E-Cadherin expression recorded by two observers. 
 
TABLE I: Shows evaluation of TGFβ1 and E-Cadherin immunostained 
sections. 
IHC feature Scoring 
E-cadherin – Tissue localization Membranous or cytoplasmic (basal, suprabasal and 
spinous) 
E-cadherin staining intensity Negative (0), mild (+), moderate (++), intense (+++) 
TGFβ1 - Tissue localization Cytoplasmic, nuclear or perinuclear (basal, 
suprabasal and spinous) 
TGFβ1 expression in stroma Present/absent 
TGFβ1 staining intensity Negative (0), mild (+), moderate (++), intense (+++) 
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 The data was entered in Microsoft excel sheet and analyzed using SPSS 
software (version 16.0). Pearson’s Chi-square test and Fisher test were done to 
compare variables between the groups and a P value <0.05 was considered 
statistically significant. The correlation between E-cadherin localization and 
TGFβ1 intensity was calculated using Kendall’s tau-b test. The value was 
considered significant, if less than 0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
  
Figure-1. The clinical photographs of the patients in OSMF Group I, Group II and 
Group III in the first, second and third rows respectively. 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure-2. The photograph shows the primary antigens and the secondary antibody 
kit used in the study. 
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RESULTS 
 
 The analysis of the OSMF Groups I to III, plus the additional six cases of 
non-OSMF with routine and immuno-stained sections for TGFβ1 and E-cadherin 
revealed the following observations in the present study. 
 
HISTOPAHOLOGICAL EVALUATION  
Hematoxylin and eosin stained (H&E) sections of all the 30 OSMF 
samples were evaluated for the parameters assessed and the results are shown in 
the Table II. Of the parameters assessed, vascularity and dense fibrosis were 
almost universal findings in all the samples, but thickening of the basement 
membrane in OSMF Group I was only statistically significant (p=0.027). Six non-
OSMF cases showed atrophic and hyperplastic epithelium. 
  
Table II. Shows the results of the histological parameters assessed in this 
study.  
 Group I (%) Group II (%) Group III (%) 
Keratinization (P) 67 71 90 
Keratinization (O)  7  
Atrophy & Hyperplasia 83 36 50 
Hyperplasia - 44 50 
Epithelial dysplasia - 100  
Carcinoma   100 
Subepithelial inflammation Mild (67) Moderate (43) Moderate (50) 
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Hyaline material 67 36 20 
Basement membrane 
thickening 
83 29 20 
Vascularity 
Moderate or 
increased 
Moderate or 
increased 
Moderate or 
increased 
Fibrosis Dense Dense Dense 
(P) = para, (O) = ortho 
 
IMMUNOHISTOCHEMICAL EVALUATION 
The spatial distribution of positive immunoreactivity was interpreted as 
cytoplasmic and nuclear labelling in epithelial and connective tissue cells for 
TGFβ1 and membranous or cytoplasmic for E-cadherin. The intensity of staining 
was assessed using a semiquantitative method.  A scale of 0 to +++ was used, 3+ 
intense, 2+ moderate, and 1+ mild, whereas 0 indicated absence of staining. All 
sections were independently assessed by two pathologists.  
 
INTENSITY AND PATTERN OF E-CADHERIN STAINING REACTION 
The distribution pattern of E-cadherin revealed that the normal epithelium 
(non-OSMF) and as well as the epithelium in OSMF (all Groups) exhibited the 
membranous and cytoplasmic staining patterns in varying proportions and extent.  
 
PATTERN OF E-CADHERIN STAINING REACTION 
In the normal epithelium (non-OSMF), the pattern of E-cadherin staining 
reaction was both membranous and cytoplasmic reaction (basal to suprabasal 
layers) in the atrophic and hyperplastic regions (Figure-3). In OSMF (Group I), 
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there was predominance of a membranous pattern compared to the cytoplasmic 
pattern (basal to suprabasal layers) (Figure-4). In OSMF (Group II), the 
cytoplasmic pattern extended to the spinous cell layers both in the dysplastic 
region and in the adjacent normal epithelium (Figure-5). In contrast, the 
cytoplasmic pattern extended to the spinous cell layers in the apparently normal 
epithelium of OSMF (Group III), but not in the vicinity of malignant 
transformation (Figure-6 & 7) and Graph I. 
 
INTENSITY OF E-CADHERIN STAINING REACTION 
Immunoreactivity to E-cadherin showed an intense staining reaction in the 
normal atrophic and hyperplastic epithelium (non-OSMF) (Figure-3). Similar 
intensity of E-cadherin staining is also exhibited in OSMF (Group I to III) 
(Figure-4 - 7), but there is a decline in the intensity of membranous expression of 
E-cadherin from OSMF (Group I to III) (Figure-4 - 7) and Graph II. 
 
INTENSITY AND PATTERN OF TGFβ1 STAINING REACTION 
The intensity of TGFβ1 staining reaction is moderate to intense in non-
OSMF and mild to moderate in OSMF (Group I) (Figure-8), but moderate to 
intense in OSMF (Group II and III) (Figure 9) and Graph III. The distribution 
pattern of TGFβ1 exhibited nuclear staining reactions in the epithelium of non-
OSMF and OSMF (Group I) (Figure-8). In OSMF (Group II & III), both 
nuclear and cytoplasmic pattern are evident, but the latter reaction is noted mainly 
in Group III (Figure-9).   
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CORRELATION OF INTENSITY AND PATTERN OF TGF AND E-
CADHERIN STAINING REACTION 
In general, the intensity of TGFβ1 increased from 16% of cases in OSMF 
(Group I) to around 60% of cases in OSMF (Group II and III), respectively, 
which correlates with increasing grades of epithelial dysplasia and invasive 
squamous cell carcinoma. Similarly, the E-cadherin expression becomes more 
cytoplasmic in the spinous cell layers of 36% of cases in OSMF (Group II) and 
80% of cases in OSMF (Group III). Thus, with a moderate to intense TGFβ1 
reaction, there is an increase in the cytoplasmic staining pattern to E-cadherin in 
the spinous cell layers from 42% cases to 60% of cases, indicating a positive 
correlation (Kendall’s tau-b-0.250) – Table III. In contrast, the intensity of 
cytoplasmic and membranous patterns to E-cadherin declines and takes a mild 
membranous character at the point of abrupt transition from the apparently normal 
epithelium to invasive squamous cell carcinoma (Figure-6, 7 & 9C, F, I & L). 
The latter finding is reverse of the reaction with TGFβ1 which becomes more 
intense with progression from epithelial dysplasia to carcinoma-in-situ and thence 
to malignancy (Figure 9B, E, H & K).  In addition, the declining E-cadherin 
expression regains a relatively intense membranous and cytoplasmic staining 
pattern in the smaller invasive tumour clusters or squamous tumour islands found 
at a depth from the surface similar to its reaction (Figure-10). 
 
Interestingly, the intense membranous and cytoplasmic staining pattern to 
E-cadherin was also observed in the apparently normal epithelium, in OSMF 
(Group II and III), both close to and away from the focus of epithelial dysplasia, 
carcinoma-in-situ and invasive squamous cell carcinoma (Figure 11). 
  
 
Graph I. Cytoplasmic reaction of E-cadherin in OSMF Groups I, 
II and III. (B-Basal, SB-Suprabasal, S-Spinous) 
 
 
 
 
Graph II. Intensity of E-cadherin staining reaction in OSMF Groups I, 
II and III. 
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Graph III. The intensity of TGFβ1 staining reaction in OSMF Groups I, 
II and III. 
 
 
 
 
 
  
EC-cytoplasmic staining 
localization 
TGFβ1 
intensity 
Kendall's 
tau_b 
EC-cytoplasmic staining 
localization 
1.000 .250 
. .163 
30 30 
TGFβ1intensity 
.250 1.000 
.163 . 
30 30 
 
Table III.  Correlation between intensity of tgf-beta1 expression and 
cytoplasmic e-cadherin localization 
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DISCUSSION 
 
 In India, oral cancer account for more than 30% of all cancers diagnosed 
and is the third most common type of cancer.
4
 There is an increasing trend of 
younger patients with oral cancer which is mainly attributed to the habitual use of 
tobacco and areca nut products which are implicated strongly in the development 
of OSMF. Though clinicians are swift in suspecting malignant transformation of 
OSMF, and request histopathological correlation, most of the time convincing 
histopathological corroboration remains elusive due to lack of adequate tissue 
sampling or inadequate morphological alterations necessary to deem malignant 
transformation. Therefore, this study was undertaken with the intention to explore 
the usefulness of E-cadherin and TGFβ1 immuno-staining as an adjunct to predict 
malignant transformation of oral epithelium in the context of OSMF.  
 
 The present study demonstrates that increased cytoplasmic expression of 
E-cadherin accompanied by the expansion of staining reaction to the spinous cell 
layers is related to the intense reaction to TGFβ1. The present study also show that 
the associated apparently normal epithelium, in the context OSMF group II and III 
exhibited a more or less similar reaction pattern. In addition, the intensity of both 
cytoplasmic and membranous patterns of E-cadherin declines at the invasive 
margins of the tumour epithelium, but with progressive gain of intensity with 
TGFβ1 in all layers of the epithelium. The decline in E-cadherin intensity is 
followed by gain of mild to moderate membranous and cytoplasmic staining 
patterns in the invasive individual tumour clusters and in solid tumour islands.  
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 Although TGFβ1 plays a central role in the pathogenesis of OSMF, the 
literature on TGFβ1 expression in the oral epithelium in the context of OSMF is 
sparse.  
 
 The available literature shows that TGFβ1 is strongly expressed in the 
epithelium of OSMF but not in the normal oral epithelium.
50
 In contrast, others 
have found TGFβ1 expression throughout the normal epithelium and epithelium in 
OSMF.
56 
In an immunohistochemical observation by Khan et al,
7
 a strong 
expression of TGFβ1 in the surface epithelium of OSMF was observed compared 
to mild to moderate staining in normal tissue. In another study by Kale et al,
65
 
TGFβ1 staining was noted more in the basal compartment with intense reaction in 
the early compared to advanced stages of OSMF.  
 
 In the present study, compared to the epithelium in non-OSMF, there was 
proportionate increase in the intensity and expansion of TGFβ1 staining in the 
spinous cell layers of OSMF (Groups II and III). Our observations are in 
accordance with the expression of TGFβ1 in the normal epithelium and in the 
epithelium of OSMF. However, a recent study reported high levels of TGFβ1in 
the normal labial epithelium compared to low levels in epithelial dysplasia in the 
context of actinic cheilitis and labial squamous cell carcinoma.
67
  
 
 It has been suggested from experiment using transgenic mice that intense 
overexpression of TGFβ1 in the head and neck epithelia may be an important 
molecular mechanism driving epithelial cells towards tumorigenesis via chronic 
inflammation.
53
 A study revealed in oesophageal carcinogenesis, that linear 
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correlation exists between the expression of α-SMA fibroblasts and expression of 
TGFβ1 from intraepithelial carcinoma to squamous cell carcinoma indicating that 
overexpression of TGFβ1 with suitable microenvironment in the stroma may be 
involved in the increased proliferation of oesophageal epithelial cells.
61
 Increased 
TGFβ1 expression in cervical intraepithelial carcinoma and invasive carcinoma 
also correlates with increase in the malignant transformation of intraepithelial 
carcinoma mediated by myofibroblasts.
55
 Another observation from lung 
adenocarcinoma found that increase in TGFβ1 precedes loss of E-cadherin 
expression indicating that TGFβ1 overexpression is an initial event in the invasive 
process.
62
  
 
 As to how an increase in the levels of expression of TGFβ1 in the oral 
epithelium might be related to its ability to suppress or promote epithelial 
tumorigenesis?  It has been held that though TGFβ1 act as a growth inhibitor of 
most epithelial cells, loss or attenuation of the TGFβ1 signaling pathway 
(including non-functional TβRII and TβRIII) enhances epithelial carcinogenesis. 
This is because in the absence of functional receptors, the carcinoma cells are 
insensitive to the action of TGFβ1 which is frequently accompanied by increased 
expression of TGFβ1 by the same cells.13 Our results also show that there is 
increased expression of TGFβ1 in the epithelium in the context of OSMF (Group 
II and III) compared to the normal epithelium (non-OSMF) and OSMF (Group 
I) (Figure-8 & 9). It has been further hypothesized that the increased expression 
of TGFβ1 by tumour cells during progression stimulates down-regulation of 
TβRII and TβRIII in the oral epithelium and in the stroma, leading to reduction of 
apoptosis.
6
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 It is significant to note, in the present study, that loss of membranous 
reaction pattern or gain of cytoplasmic reaction pattern to E-cadherin positively 
correlates with the intensity of TGFβ1 (Figure-9).  
 
 It has been widely reported that loss of E-cadherin expression leads to loss 
of cellular cohesion, and thus, the cells become motile and free to move away 
from each other with the gradual progression of epithelial dysplasia towards 
malignancy. Interestingly, TGFβ1, as noted above,11,13 also initiates tumorigenic 
events by mediating loss of adherens junction. Therefore, the down-regulation of 
E-cadherin due to mutation, as assessed by the intensity of E-cadherin staining in 
a membranous pattern, has been largely linked to the increasing grades of 
epithelial dysplasia, and is believed to serve to as an indicator of impending 
malignancy. Unfortunately, however, such an event is considered as a late event in 
the genesis of malignancy because loss of E-cadherin expression is best correlated 
with the advancing front of the tumour or poorly differentiated phenotype 
suggesting that reduction or loss of expression of E-cadherin is associated with 
invasiveness and metastasiss.
14,68,71 
 
 Review of the literature revealed a strong membranous expression of E-
cadherin throughout the normal or hyperplastic oral epithelium but not in the 
surface or keratinized cell layers.
14,68,71,73,78,81
 The present observation is similar to 
the published series insofar as it relates to the normal atrophic and hyperplastic 
epithelium (non-OSMF), and those related to OSMF (Group I).  However, 
cytoplasmic pattern was also evident in the basal compartment of non-OSMF and 
OSMF (Group I).  
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 According to the literature, the intense membranous staining pattern to E-
cadherin becomes gradually reduced with progression of normal epithelium 
through varying grades of epithelial dysplasia,
68,71,81
 but tends to accumulate an 
increase in the cytoplasmic staining pattern.
68,81
 The latter feature is generally 
conspicuous when epithelial dysplasia is associated with adjacent infiltrating 
squamous cell carcinoma.
68
 Further, the expression of E-cadherin becomes 
gradually reduced or lost at the invasive front of the tumour but followed by 
acquisition of membranous pattern in the better differentiated cells of the tumour 
islands.
68,82
 The significant information that emerges from these studies, and from 
the present study, is that the membranous pattern of E-cadherin decreases in 
severe epithelial dysplasia compared to the normal epithelium, but is accompanied 
by a gradual increase in the cytoplasmic pattern with progression from normal to 
varying grades of epithelial dysplasia (Figure-3, 4 & 9).  
 
 The literature also shows that expression of E-cadherin becomes down-
regulated with the progression of epithelial dysplasia in OSMF compared to 
OSMF without epithelial dysplasia and in the normal oral epithelium.
46,77
 These 
authors’ believe that the loss of intensity in staining with E-cadherin might well 
indicate the progression towards malignant transformation of OSMF. However, 
the present study is at variance in that both cytoplasmic and membranous staining 
to E-cadherin was also observed in the atrophic, hyperplastic and dysplastic 
epithelium in OSMF (Group I and II) (Figure-3 – 7 & 9), but with more intense 
cytoplasmic staining in greater proportion of cells in the latter epithelium (Group 
II). Thus the present observation is diametrically opposite to the report by Das
77
 
et al, 2010 in OSMF and others, in relation to epithelial dysplasia without 
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OSMF.
68,81
 However, in subsequent studies by the same group,
46,90
 the authors’ 
have observed a similar expression pattern of E-cadherin as found in their 
previous study,
77
 but the expression of E-cadherin shifted from a membranous to a 
cytoplasmic staining pattern in greater proportion of cells with increasing grades 
of dysplasia associated with OSMF. While this observation is consistent with the 
present study, E-cadherin expression also exhibited in the apparently normal 
epithelium both close to and away from the region of epithelial dysplasia, 
carcinoma in-situ and invasive squamous cell carcinoma within the same sections 
(Figure-11). Therefore, it is evident from the foregoing that there is a reduction in 
the membranous- and gains of cytoplasmic pattern of E-cadherin regardless of 
whether epithelial dysplasia is related to OSMF or not.
46,68,90
 However, prominent 
cytoplasmic expression of E-cadherin has been observed by others, in 
bronchopulmonary carcinomas,
72
 to be specifically restricted to invasive nests but 
not in the in-situ lesions. These authors’ suggest that expression of cytoplasmic E-
cadherin is a prerequisite for tumour cells to acquire an invasive phenotype.
72
  
 
 The literature shows that a heterogeneous pattern with areas of intense 
staining and loss of membranous or gain of cytoplasmic staining to E-cadherin 
characterizes squamous cell carcinoma,
71,73,78,84
 In addition, individual tumour 
cells or small squamous islands tend to be completely negative for E-cadherin 
staining, which has been linked to the infiltrative process.s
71
 In comparison, in the 
present study, the cytoplasmic expression of E-cadherin becomes inconspicuous 
but takes a mild to moderate membranous staining pattern in the region of 
invasive front adjacent to the apparently normal epithelium in OSMF (Group III) 
(Figure-7 & 9L).  In the individual tumour clusters at a depth from the surface, 
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there is gain of cytoplasmic and membranous staining pattern (Figure-10). It has 
been reported that the cytoplasmic expression of E-cadherin becomes reduced in 
endometrial carcinomas compared to the normal proliferative phase of 
endometrial glands,
74
 a finding also consistent with the present observation in 
OSMF (Group III). The expression of cytoplasmic staining of E-cadherin has 
also been regarded as a prominent alteration in both unfixed frozen and formalin-
fixed paraffin-embedded tissue sections of oral squamous cell carcinoma.
49,73,83
 
Therefore, no clear clarity of thought emerges from the diverging views with 
regard to the timing of gain or loss of cytoplasmic expression of E-cadherin. 
 
 It is evident from the available literature that the loss of membranous E-
cadherin staining is attributed to a late event in the progression of oral epithelial 
dysplasia to malignancy and is also hypothesized that re-establishment of a 
membranous staining pattern relates to recapitulation of normal architecture but 
still retains a malignant phenotype.
68,71
 Further, as noted above, that reduction/loss 
or gain of E-cadherin (both membranous and cytoplasmic) is related to 
invasiveness or metastasis which is a late event in the progression of epithelial 
cancer, and as such, is unlikely to portend early clue to malignant transformation 
in high-risk cases of OSMF. In this context, the reported expression of E-cadherin 
in the spinous layer of apparently normal epithelium adjacent to oral squamous 
cell carcinoma lend credence to our similar observation (Figure-11).
73
  
 
 In agreement with the data published before, the data presented in this 
study further suggest that moderate to intense E-cadherin staining (membranous 
and/or cytoplasmic) even in the apparently normal epithelium in the context of 
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OSMF Group II and III might well indicate the potential for transition of OSMF to 
a malignant phenotype. However, we exercise caution due to the limited sample 
size of this study, and as well as to the reported, in oral squamous cells carcinoma, 
reduction or loss of expression of E-cadherin staining in non-tumour epithelium 
both close to and away from the tumour.
82
 Therefore, the salient observations of 
the present study need to be validated or refuted by further studies in a similar 
clinical setting. 
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CONCLUSION 
 
 In conclusion, the present study demonstrates that intensity of TGFβ1 
proportionately increases with progression from the normal epithelium to 
epithelial dysplasia accompanied by reduction of membranous and gain of 
cytoplasmic staining pattern to E-cadherin, but the intensity and pattern of staining 
reaction to E-cadherin inverts from the beginning of malignant transformation. In 
addition, we suggest that moderate to intense cytoplasmic reactions to E-cadherin 
in the apparently normal epithelium in a subset of OSMF might indicate the 
potential for malignant transformation.  
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 Figure-3. The photomicrograph shows representative atrophic and hyperplastic epithelium of non-OSMF in (A, B 
& C) with a membranous staining pattern in (D – F), but both membranous and cytoplasmic pattern in (F). H&E, 
x100, x400; E-cadherin, x100, x400. 
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 Figure-4. The photomicrograph shows normal epithelium of OSMF Group I in (A & B). The intense 
membranous staining reaction with E-cadherin is evident in (B). Note the conspicuous cytoplasmic 
staining pattern. H&E, x400; E-cadherin, x400. 
A      B       
 Figure-5. The photomicrograph (OSMF Group II) shows epithelial dysplasia (A) 
and intense E-cadherin membranous and cytoplasmic staining reaction with the 
latter involving the entire thickness of the epithelium in (B). H&E, x100; E-
cadherin, x100. 
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 Figure-6. The representative photomicrograph of OSMF Group III, which 
shows the transition of apparently normal epithelium to carcinoma-in-situ in (A) 
and intense and increased E-cadherin cytoplasmic staining reaction in (B) in the 
in-situ focus. Note the relative intensity of cytoplasmic staining reaction 
between the adjacent epithelium and the carcinoma-in-situ focus and the decline 
in the intensity of membranous staining pattern in the adjacent epithelium. 
H&E, x100; E-Cadherin, x100. 
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Figure-7. The representative photomicrograph of OSMF Group III in (A), which shows 
decreased expression of cytoplasmic pattern to E-cadherin in the immediate vicinity of 
invasive squamous cell carcinoma and as well as both decrease in the intensity and 
expression of membranous and cytoplasmic patterns in the invasive squamous cell 
carcinoma compared to the adjacent normal epithelium in (C & D). H&E, x40; E-cadherin, 
x40, x400. 
 
 
 
 
 
 
 
 
 
 
               
 
Figure-8. The photomicrograph of non-OSMF and OSMF Group I in (A & B) shows the  
moderately intense nuclear staining of TGFβ1. TGFβ1, x 400. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure-9. The photomicrographs show varying grades of epithelial dysplasia and squamous cell 
carcinoma in column 1. The corresponding TGFβ1 and E-cadherin in columns 2 and 3, 
respectively. Note that the grades of epithelial dysplasia and squamous cell carcinoma correlates 
with increasing intensity of TGFβ1. Similarly, the intensity of TGFβ1 correlates with increasing 
cytoplasmic expression of E-cadherin till the point of malignant transformation. H&E, x100, 
x400; TGFβ1, x100, x400; E-cadherin, x100, x400. 
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 Figure-10. The photomicrograph shows gain of membranous in (A) and cytoplasmic 
staining pattern in (B) with moderate to intense staining reaction to E-cadherin in the 
tumour cells at a depth from the surface epithelium. E-cadherin, x400  
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Figure-11. The photomicrographs show a OSMF Group III lesion with normal epithelium 
showing gradual transition to carcinoma-in-situ as shown in (A). The E-cadherin staining is 
shown in (B). The insets marked in (A) is shown in (C – H) with C to D showing routine section 
of normal epithelium in (C), hyperplasia in (D) and carcinoma-in-situ (E). Note the difference in 
the intensity of cytoplasmic pattern to E-cadherin from (F – H). H&E, x40, x400; E-cadherin, 
x40, x400. 
 
 
 
 
 
 
